LinkedIn Profile

Access Retia Medical historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:retiamedical 2587771 Dec 3rd, 2020 12:00AM Retia Medical 555 9.00 Open Medical Device Dec 3rd, 2020 12:41PM Dec 3rd, 2020 12:41PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Dec 2nd, 2020 12:00AM Retia Medical 554 9.00 Open Medical Device Dec 2nd, 2020 03:05PM Dec 2nd, 2020 03:05PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Dec 1st, 2020 12:00AM Retia Medical 554 9.00 Open Medical Device Dec 1st, 2020 02:27PM Dec 1st, 2020 02:27PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 30th, 2020 12:00AM Retia Medical 554 9.00 Open Medical Device Nov 29th, 2020 08:30PM Nov 30th, 2020 03:18PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 28th, 2020 12:00AM Retia Medical 554 9.00 Open Medical Device Nov 28th, 2020 04:05PM Nov 28th, 2020 04:05PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 27th, 2020 12:00AM Retia Medical 554 9.00 Open Medical Device Nov 27th, 2020 12:31PM Nov 27th, 2020 12:31PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 26th, 2020 12:00AM Retia Medical 554 9.00 Open Medical Device Nov 25th, 2020 07:15PM Nov 26th, 2020 01:29PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 24th, 2020 12:00AM Retia Medical 553 9.00 Open Medical Device Nov 24th, 2020 02:36PM Nov 24th, 2020 02:36PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 23rd, 2020 12:00AM Retia Medical 552 9.00 Open Medical Device Nov 23rd, 2020 04:35PM Nov 23rd, 2020 04:35PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services
private:retiamedical 2587771 Nov 22nd, 2020 12:00AM Retia Medical 552 9.00 Open Medical Device Nov 22nd, 2020 03:32PM Nov 22nd, 2020 03:32PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Retia Medical Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.